Publication | Open Access

FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)

Breast OncologyOncologyRandomized StudyCancer ManagementAdjuvant ChemotherapyGynecologyBreast CancerPharmacotherapyCancer TreatmentMedicineGynecology Oncology